欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
OT-R antagonist 2_364071-16-9_产品详情
364071-16-9
  • OT-R antagonist 2

  • names:

    OT-R antagonist 2

  • CAS号:

    364071-16-9

    MDL Number:
  • MF(分子式): C28H29N3O4 MW(分子量): 471.55
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
OT-R antagonist 2
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM004196-5mg 5mg 99.74% ¥ 13365.00 ¥ 13365.00 2-3天
- +
¥ 0.00
YZM004196-1mg 1mg 99.74% ¥ 4550.00 ¥ 4550.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 364071-16-9
Inchi
InchiKey
分子式 Formula C28H29N3O4
分子量 Molecular Weight 471.55
溶解度Solubility
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
OT-R antagonist 2(CAS:364071-16-9)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 OT-R antagonist 2 is a nonpeptide low molecular weight OT-R antagonist. OT-R antagonist 2 inhibitis IP3-Synthesis, rat OT-R (IC50 = 0.33 μM). IC50 value: 0.33μM
IntroductionOT antagonist 2 is a nonpeptide low molecular weight OT antagonist. OT antagonist 2 inhibitis IP3ynthesis, rat OT (IC50 = 0.33 μM). IC50 value: 0.33μM
Application1
Application2
Application3
OT-R antagonist 2 is a nonpeptide low molecular weight OT-R antagonist. OT-R antagonist 2 inhibitis IP3-Synthesis, rat OT-R (IC50 = 0.33 μM). IC50 value: 0.33μM Target: oxytocin receptor
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Cirillo R, et al. Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor. J Pharmacol Exp Ther. 2003 Jul;306(1):253-61.
【2】.William Nadler, et al. Method for preparing pyrrolidine oximes. WO/2005082848/A2.
【3】.Serge Halazy, et al. Pharmaceutically active pyrrolidine derivatives as bax inhibitors.WO/2001074769/A1.
【4】.Serge Halazy, et al. Pharmaceutically active pyrrolidine derivatives as bax inhibitors. WO/2001072705/A1.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents